Electromed (ELMD) Cash from Investing Activities (2010 - 2026)
Electromed's (ELMD) quarterly Cash from Investing Activities came in at -$223000.0 in Q2 2026, down 42.04% year-over-year from -$384736.3 in Q2 2025, and down 44.81% quarter-over-quarter from -$154000.0 in Q1 2026.
Powered by 
Analysis
Electromed (ELMD) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Electromed (ELMD) has reported Cash from Investing Activities for 17 consecutive years, with -$223000.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Cash from Investing Activities fell 42.04% year-over-year to -$223000.0 in Q2 2026; TTM through Jun 2026 was -$1.3 million, a 324.84% decrease from a year earlier, with the FY2026 full-year figure at -$1.3 million, down 324.84% from the prior year.
- Cash from Investing Activities was -$223000.0 for Q2 2026 at Electromed, down from -$154000.0 in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $146000.0 in Q1 2025 and troughed at -$656000.0 in Q4 2025.
- A 5-year average of -$259000.0 and a median of -$230000.0 in 2024 frame the typical range for Cash from Investing Activities.
- Across the five-year window, Cash from Investing Activities slumped 659.38% in 2022 and soared 213.18% in 2025, its largest moves.
- Over 5 years, Cash from Investing Activities stood at -$461000.0 in 2022, then soared by 81.13% to -$87000.0 in 2023, then slumped by 172.41% to -$237000.0 in 2024, then plunged by 176.79% to -$656000.0 in 2025, then jumped by 66.01% to -$223000.0 in 2026.
- The last three Cash from Investing Activities figures came in at -$223000.0 (Q2 2026), -$154000.0 (Q1 2026), and -$656000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | -26.60 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | -1.62 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | -639.00 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | -1.96 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | -193.20 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -222.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 329.80 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Electromed | 222.94 Mn | 202.49 Mn | 15.28 Mn | -223,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -223,000.00 |
| Mar 31, 2026 | -154,000.00 |
| Dec 31, 2025 | -656,000.00 |
| Sep 30, 2025 | -267,000.00 |
| Jun 30, 2025 | -157,000.00 |
| Mar 31, 2025 | 146,000.00 |
| Dec 31, 2024 | -237,000.00 |
| Sep 30, 2024 | -58,000.00 |
| Jun 30, 2024 | -46,000.00 |
| Mar 31, 2024 | -129,000.00 |
| Dec 31, 2023 | -87,000.00 |
| Sep 30, 2023 | -133,000.00 |
| Jun 30, 2023 | -441,000.00 |
| Mar 31, 2023 | -558,000.00 |
| Dec 31, 2022 | -461,000.00 |
| Sep 30, 2022 | -256,000.00 |
| Jun 30, 2022 | -459,000.00 |
| Mar 31, 2022 | -486,000.00 |
| Dec 31, 2021 | -310,000.00 |
| Sep 30, 2021 | -270,000.00 |